Distribution and drivers of costs in type 2 diabetes mellitus treated with oral hypoglycemic agents: a retrospective claims data analysis

References

• American Diabetes Association. Economic costs of diabetes in the US in 2002. Diabetes Care 2003;26:917-32
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Economic costs of diabetes in the U.S. In 2007. Diabetes Care 2008;31:596-615
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care 2013;36:1033-46
   PubMed Web of Science ®Google Scholar
• US Centers for Disease Control and Prevention. Diabetes Report Card 2012. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services, 2012. p 1-16. http://www.cdc.gov/diabetes/pubs/pdf/DiabetesReportCard.pdf. Accessed November 17, 2013
   Google Scholar
• World Health Organisation (WHO). Diabetes - Fact sheet N°312. Geneva, Switzerland: World Health Organisation; 2013. Available at: http://www.who.int/mediacentre/factsheets/fs312/en/index.html Accessed November 17, 2013
   Google Scholar
• U.S. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: national estimates and general information on diabetes and prediabetes in the United States, 2007. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2007. p 1-8. http://www.cdc.gov/diabetes/pubs/factsheet07.htm. Accessed March 13, 2013
   Google Scholar
• Maguire J, Dhar V. Comparative effectiveness for oral anti-diabetic treatments among newly diagnosed type 2 diabetics: data-driven predictive analytics in healthcare. Heal Syst 2012;2:73-92
   Google Scholar
• Borah B, Nigam S, Steinbuch M, et al. Pdb20 an analysis of differences in cost quartiles for patients with Type 2 Diabetes in a large claims database with linked laboratory results. Value Health 2010;13:A58
   Google Scholar
• Bhattacharyya SK, Else BA. Medical costs of managed care in patients with type 2 diabetes mellitus. Clin Ther 1999;21:2131-42
   PubMed Web of Science ®Google Scholar
• Bron M, Marynchenko M, Yang H, et al. Hypoglycemia, treatment discontinuation, and costs in patients with type 2 diabetes mellitus on oral antidiabetic drugs. Postgrad Med 2012;124:124-32
   PubMed Web of Science ®Google Scholar
• Gandra SR, Lawrence LW, Parasuraman BM, et al. Total and component health care costs in a non-Medicare HMO population of patients with and without type 2 diabetes and with and without macrovascular disease. J Manag Care Pharm 2006;12:546-54
   PubMed Web of Science ®Google Scholar
• The Office for Civil Rights (OCR). Guidance regarding methods for de-identification of protected health information in accordance with the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule. Washington, DC: U.S. Department of Health and Human Services, 2012. p 1-32. http://www.hhs.gov/ocr/privacy/hipaa/understanding/coveredentities/De-identification/hhs_deid_guidance.pdf. Accessed January 10, 2014
   Google Scholar
• Institute of Medicine. The Healthcare Imperative: Lowering Costs and Improving Outcomes: Workshop Series Summary. Washington, DC: The National Academies Press; 2010:1–309. Available at: http://www.nap.edu/catalog/12750.html Accessed January 10, 2014
   Google Scholar
• U.S. Bureau of Labor Statistics, Division of Consumer Prices and Price Indexes. Consumer Price Index (CPI). Washington, DC; 2014. Available at: http://www.bls.gov/cpi/home.htm Accessed April 28, 2014
   Google Scholar
• Schneeweiss S, Seeger JD, Maclure M, et al. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol 2001;154:854-64
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Checking Your Blood Glucose. Alexandria, VA: American Diabetes Association; 2013. Available at: http://www.diabetes.org/living-with-diabetes/treatment-and-care/blood-glucose-control/checking-your-blood-glucose.html?loc=hypoglycemia. Accessed January 10, 2014
   Google Scholar
• Fowler MJ. Microvascular and macrovascular complications of diabetes. Clin Diabetes. 2008;26:77-82
   Google Scholar
• Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-19
   PubMed Web of Science ®Google Scholar
• Ward A, Alvarez P, Vo L, et al. Direct medical costs of complications of diabetes in the United States: estimates for event-year and annual state costs (USD 2012). J Med Econ. 2014;17:176-83
   PubMedGoogle Scholar
• Nolan JJ, O’Halloran D, McKenna TJ, et al. The cost of treating type 2 diabetes (CODEIRE). Ir Med J 2006;99:307-10
   PubMedGoogle Scholar
• Bolin K, Gip C, Mörk A-C, et al. Diabetes, healthcare cost and loss of productivity in Sweden 1987 and 2005–a register-based approach. Diabet Med 2009;26:928-34
   PubMed Web of Science ®Google Scholar
• Colin X, Lafuma A, Gueron B. Costs of cardiovascular events of diabetic patients in the French hospitals. Diabetes Metab 2007;33:310-13
   Google Scholar
• Ray NF, Thamer M, Taylor T, et al. Hospitalization and expenditures for the treatment of general medical conditions among the U.S. diabetic population in 1991. J Clin Endocrinol Metab 1996;81:3671-9
   Web of Science ®Google Scholar
• Roy T, Lloyd CE. Epidemiology of depression and diabetes: a systematic review. J Affect Disord 2012;142(Suppl):S8-21
   PubMedGoogle Scholar
• Pan A, Lucas M, Sun Q, et al. Bidirectional association between depression and type 2 diabetes mellitus in women. Arch Intern Med 2010;170:1884-91
   PubMed Web of Science ®Google Scholar
• Simon GE, Katon WJ, Lin EHB, et al. Diabetes complications and depression as predictors of health service costs. Gen Hosp Psychiatry 2005;27:344-51
   PubMed Web of Science ®Google Scholar
• Aguilar R. Managing type 2 diabetes in men. J Fam Pract 2012;61:S16-21
   Google Scholar
• Henriksson F, Agardh CD, Berne C, et al. Direct medical costs for patients with type 2 diabetes in Sweden. J Intern Med 2000;248:387-96
   PubMed Web of Science ®Google Scholar
• Bahia LR, Araujo DV, Schaan BD, et al. The costs of type 2 diabetes mellitus outpatient care in the Brazilian public health system. Value Health 2011;14:S137-40
   PubMed Web of Science ®Google Scholar
• Furler J, Hii JWS, Liew D, et al. The ‘cost’ of treating to target: cross-sectional analysis of patients with poorly controlled type 2 diabetes in Australian general practice. BMC Fam Pract 2013;14:32
   Google Scholar